Skip to main content

Table 1 Comparing baseline clinical, laboratory, and echocardiographic variables

From: Effect of a phase 2 cardiac rehabilitation program on obese and non-obese patients with stable coronary artery disease

Variable Non-obese patients (n = 58) Obese patients (n = 62) p value
Clinical characteristics at baseline
 Age, years 54.24 ± 9.85 52.03 ± 6.48 0.313
 Female gender, n (%) 6 (10.34%) 20 (32.25%) 0.04
 Current smoker, n (%) 46 (79.31%) 32 (51.6%) 0.025
 Hypertension, n (%) 16 (27.58%) 34 (54.84%) 0.032
 Diabetes, n (%) 14 (24.13%) 24 (38.7%) 0.225
 Dyslipidemia, n (%) 14 (24.13%) 26 (41.93%) 0.144
 BMI, kg/m2 27.36 ± 1.65 33.75 ± 3.81 < 0.001
 Systolic BP, mmHg 121.03 ± 15.08 132.42 ± 16.68 0.008
 Diastolic BP, mmHg 76.38 ± 10.26 81.61 ± 9.34 0.043
 METs achieved 9.74 ± 2.47 7.97 ± 2.4 0.007
Laboratory tests at baseline
 Total cholesterol, mg/dl 170.86 ± 41.16 181.00 ± 34.48 0.304
 LDL-C, mg/dl 95.73 ± 31.51 121.63 ± 36.52 0.005
 HDL-C, mg/dl 39.34 ± 8.28 38.13 ± 8.14 0.569
 Triglycerides, mg/dl 148.86 ± 76.38 167.77 ± 60.63 0.291
 Fasting blood sugar, mg/dl 101.48 ± 24.80 109.13 ± 31.10 0.299
Echocardiographic parameters at baseline
 LVEDD, mm 52.38 ± 4.74 52.16 ± 4.51 0.856
 LVESD, mm 37.28 ± 5.52 35.97 ± 4.71 0.327
 LVEF, % 54.45 ± 8.34 56.61 ± 9.47 0.353
  1. Continuous variables are expressed as mean and standard deviation whereas categorical variables are expressed as number (percentage)
  2. BMI body mass index, BP blood pressure, METs metabolic equivalent of tasks, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, LVEDD left ventricular end-diastolic diameter, LVESD left ventricular end-systolic diameter, LVEF left ventricular ejection fraction